Lv1
80 积分 2022-12-15 加入
ELN Treatment Milestones in Chronic Myeloid Leukemia Are Prognostic for Achieving Deep Molecular Response and Treatment-Free Remission in Routine Care: Results of the German CML Registry
1个月前
已关闭
Ponatinib, asciminib and inotuzumab ozogamicin: A novel drug combination in acute lymphoblastic leukemia
1个月前
已完结
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
1个月前
已关闭
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
1个月前
已完结
A memristor-based adaptive neuromorphic decoder for brain–computer interfaces
2个月前
已完结
DNMTi@ZIF-8 Enhances Biomimetic Pulp Regeneration via Epigenetic Regulation
2个月前
已完结
Bifunctional P450 Catalyzes Sequential Hydroxylation and Macrocyclization in Emestrin A Biosynthesis
2个月前
已完结
A novel MST1-targeting kinsenoside derivative K30 attenuates acute kidney injury by restoring mitochondrial homeostasis
2个月前
已完结
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
3个月前
已完结
Novel treatment strategies for chronic myeloid leukemia
5个月前
已完结
皖公网安备34019202002308
